India Oxygen Therapy Market Outlook to 2028

India Oxygen Therapy Market Overview

The India Oxygen Therapy market is valued at USD 2.1 billion, driven primarily by the increasing prevalence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. The market growth is also supported by a rising demand for home-based oxygen therapy solutions, especially in response to the increased healthcare needs during and after the pandemic.

The dominant regions in the market include metropolitan cities like Delhi, Mumbai, and Bangalore, where there is a higher prevalence of respiratory conditions due to pollution and dense populations. Additionally, these cities benefit from advanced healthcare infrastructure and higher purchasing power, allowing for greater adoption of oxygen therapy solutions.

The Indian governments PMBJP scheme, aimed at providing affordable medicines and medical devices, has extended its support to include oxygen therapy devices in 2024. Under this initiative, the government plans to subsidize the cost of oxygen concentrators and cylinders by INR 10 billion, focusing on providing these devices to lower-income households and public hospitals.

India Oxygen Therapy Market Segmentation

By Product Type: The market is segmented by product type into oxygen concentrators, oxygen cylinders, and liquid oxygen devices. Recently, oxygen concentrators have held a dominant market share due to their portability and ease of use, making them the preferred choice for both hospitals and home healthcare settings. The shift toward home-based healthcare has further propelled the demand for oxygen concentrators, particularly in urban areas where healthcare services are more advanced.

By End User: The market is also segmented by end user into hospitals & clinics, home healthcare, and ambulatory care centers. Hospitals & clinics dominate the market, accounting for the largest share due to the increasing number of patients requiring oxygen therapy for both acute and chronic respiratory conditions. Hospitals have a greater demand for oxygen cylinders and liquid oxygen devices, especially for critical care units where high-flow oxygen is required. Home healthcare settings are experiencing rapid growth as well, driven by the increasing adoption of home oxygen therapy for long-term care of patients.

India Oxygen Therapy Market Competitive Landscape

The market is dominated by both global and local players, with a few key companies holding significant market shares. The competition is driven by product innovation, pricing strategies, and distribution networks. Local manufacturers have been able to establish a presence by offering affordable products that cater to domestic demand, while global players like Philips and Res Med continue to dominate with advanced technology and brand reputation.

Company

Year Established

Headquarters

Market Presence

Product Innovation

No. of Employees

Product Portfolio

R&D Investments

Geographical Reach

End-User Focus

Philips Healthcare

1891

Netherlands

Res Med Inc.

1989

USA

Invacare Corporation

1885

USA

Drive De Vilbiss Healthcare

2000

USA

Linde Healthcare

1879

Germany

India Oxygen Therapy Market Analysis

Market Growth Drivers

Rising Incidence of Respiratory Diseases: India is experiencing an increase in respiratory conditions like chronic obstructive pulmonary disease (COPD) and asthma, which are driving demand for oxygen therapy devices. According to the Indian Chest Society, over 30 million Indians suffer from asthma, while nearly 55 million people are affected by COPD. These figures represent a growing pool of patients who require oxygen therapy, particularly as air pollution worsens across the country.

Growing Geriatric Population: India's aging population is another factor bolstering the demand for oxygen therapy. By 2024, it is estimated that the number of people over the age of 60 will exceed 180 million, creating higher demand for medical interventions related to respiratory health. This demographic shift is leading to a surge in chronic respiratory conditions that require long-term oxygen therapy as part of patient management.

Expansion of Home Healthcare Services: Indias home healthcare sector is expanding rapidly due to rising healthcare costs and the need for long-term care, particularly for respiratory conditions. By 2024, the home healthcare market in India is projected to treat nearly 5 million chronic patients, many of whom require oxygen therapy as a core treatment. The demand for oxygen concentrators and cylinder-based systems is surging, especially in urban areas where patients prefer home care solutions to hospital-based treatments due to convenience and cost savings.

Market Challenges

Limited Awareness and Training Among Healthcare Providers: Despite the rising demand for oxygen therapy, there is still limited awareness among healthcare providers about the proper use and benefits of these devices, particularly in rural areas. In 2024, a survey by the Indian Medical Association revealed that over 40% of doctors in Tier-II and Tier-III cities are not fully trained in prescribing or managing oxygen therapy effectively, which can result in suboptimal care for patients requiring respiratory support.

Regulatory Hurdles and Compliance: The Indian medical device regulatory framework has been evolving, but oxygen therapy devices still face a slow and complex approval process. The Central Drugs Standard Control Organization (CDSCO) has reported that in 2024, only about 60% of oxygen therapy devices on the market are fully compliant with national regulations, which can lead to quality control issues.

India Oxygen Therapy Market Future Outlook

Over the next five years, the India Oxygen Therapy industry is expected to witness substantial growth, driven by rising incidences of respiratory diseases, increasing adoption of home-based healthcare, and advancements in oxygen therapy technologies.

Future Market Opportunities

Government-Funded Expansion of Oxygen Therapy in Rural Areas: Over the next five years, the Indian government will likely continue its efforts to expand access to oxygen therapy in rural areas. Through continued investments in healthcare infrastructure, including setting up oxygen production plants and subsidizing oxygen therapy devices, access to medical oxygen is projected to improve dramatically by 2029.

Integration of AI for Monitoring Oxygen Therapy Devices: In the future, we will see an increased integration of artificial intelligence (AI) and remote monitoring systems in oxygen therapy devices. By 2029, AI-driven oxygen therapy systems are expected to be commonplace in Indias urban hospitals, allowing healthcare professionals to remotely monitor patients oxygen levels and adjust treatments in real-time.
Please Note: It will take 5-7 business days to complete the report upon order confirmation